Benign prostatic hyperplasia
MONDO:0010811A non-cancerous nodular enlargement of the prostate gland. It is characterized by the presence of epithelial cell nodules, and stromal nodules containing fibrous and smooth muscle elements. It is the most common urologic disorder in men, causing blockage of urine flow.
Also known as: prostate hypertrophy, prostatic hypertrophy, benign hyperplasia of prostate, benign hyperplasia of the prostate, benign prostate hyperplasia, benign prostatic Hypertrophy, benign prostatic hyperplasia, benign prostatic hyperplasia (disease)
179 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Hormone pill tested for prostate troubles – but trial halted early
Disease control TerminatedThis phase 2 trial tested a hormone drug called etonogestrel (Org 3236) in 16 men with moderate to severe urinary symptoms from an enlarged prostate. The goal was to see if the drug could shrink the prostate, improve urine flow, and boost quality of life compared to a placebo. Ho…
Phase: PHASE2 • Sponsor: Organon and Co • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Promising prostate device trial halted after just one patient
Disease control TerminatedThis study tested a new device that uses water electrolysis to shrink prostate tissue and relieve urinary symptoms in men with benign prostatic hyperplasia (BPH). The goal was to see if it could improve symptoms by at least 30% and be safe. However, the trial was terminated early…
Phase: NA • Sponsor: ProstaCare Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC